» Articles » PMID: 29331422

FePt-Cys Nanoparticles Induce ROS-dependent Cell Toxicity, and Enhance Chemo-radiation Sensitivity of NSCLC Cells In vivo and In vitro

Overview
Journal Cancer Lett
Specialty Oncology
Date 2018 Jan 15
PMID 29331422
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

FePt-Cys nanoparticles (FePt-Cys NPs) have been well used in many fields, despite their poor solubility and stability. We synthetized a cysteine surface modified FePt NPs, which exhibited good solubility, stability and biocompatibility. We explored the insight mechanisms of the antitumor effects of this new nanoparticle system in lung cancer cells. In the in vitro study, FePt-Cys NPs induced a reactive oxygen species (ROS) burst, which suppressed the antioxidant protein expression and induced cell apoptosis. Furthermore, FePt-Cys NPs prevented the migration and invasion of H1975 and A549 cells. These changes were correlated with a dramatic decrease in MMP-2/9 expression and enhanced the cellular attachment. We demonstrated that FePt-Cys NPs promoted the effects of chemo-radiation through activation of the caspase system and impairment of DNA damage repair. In the in vivo study, no severe allergies or drug-related deaths were observed and FePt-Cys NPs showed a synergistic effect with cisplatin and radiation. In conclusion, with good safety and efficacy, FePt-Cys NPs could therefore be potential sensitizers for chemoradiotherapy.

Citing Articles

Current advance of nanotechnology in diagnosis and treatment for malignant tumors.

Wang B, Hu S, Teng Y, Chen J, Wang H, Xu Y Signal Transduct Target Ther. 2024; 9(1):200.

PMID: 39128942 PMC: 11323968. DOI: 10.1038/s41392-024-01889-y.


Application of nano-radiosensitizers in non-small cell lung cancer.

Hu X, Hu J, Pang Y, Wang M, Zhou W, Xie X Front Oncol. 2024; 14:1372780.

PMID: 38646428 PMC: 11027897. DOI: 10.3389/fonc.2024.1372780.


Reactive oxidative species (ROS)-based nanomedicine for BBB crossing and glioma treatment: current status and future directions.

Wu D, Chen X, Zhou S, Li B Front Immunol. 2023; 14:1241791.

PMID: 37731484 PMC: 10507261. DOI: 10.3389/fimmu.2023.1241791.


Green Synthesis of Platinum Nanoparticles for Biomedical Applications.

Mikhailova E J Funct Biomater. 2022; 13(4).

PMID: 36412901 PMC: 9680517. DOI: 10.3390/jfb13040260.


Tantalum-carbon-integrated nanozymes as a nano-radiosensitizer for radiotherapy enhancement.

Li R, Zhao W, Wu T, Wang A, Li Q, Liu Y Front Bioeng Biotechnol. 2022; 10:1042646.

PMID: 36353740 PMC: 9638097. DOI: 10.3389/fbioe.2022.1042646.